Document Details
Form
Filing Date
Mar 11, 2024
Document Date
Mar 7, 2024
Form Description
Statement of changes in beneficial ownership of securities
Filing Group
3,4,5
Company
Ultragenyx Pharmaceutical Inc.
Issuer
Ultragenyx Pharmaceutical Inc.
Filer
Fust Matthew K